Demand for hospital resources are likely to increase by the end of January 2021 – with a distinctly sharper rate of increase for hospital beds relative to ICU ventilators and other equipment needed for critically ill COVID-19 patients.
This suggests that while cases are rising, the ratio of critically ill cases to total cases will be lower than in the initial surge seen in the early parts of 2020.
Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...
Read more
